BriaCell Therapeutics Corp (TSX:BCT) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of units (one common share or pre-funded warrant and one warrant) Closed: US$30M raised · US$5.59 a unit · 1 warrant at US$6.93 for 60 months · ThinkEquity Dealers: ThinkEquity (lead) Use of proceeds: Working capital, general corporate purposes and advancing the company's business objectives | Jan 15, 2026 |
| Public offering of units (one common share or pre-funded warrant and one warrant) Closed: US$15M raised · US$1.25 a unit · 1 warrant at US$1.5 for 60 months · ThinkEquity Dealers: ThinkEquity (lead) Use of proceeds: Working capital, general corporate purposes and advancing business objectives | Jul 16, 2025 |
| Public offering of units (one common share or pre-funded warrant and one warrant) Closed: US$13.8M raised · US$4.5 a unit · 1 warrant at US$5.25 for 60 months · ThinkEquity Dealers: ThinkEquity (lead) Use of proceeds: Working capital, general corporate purposes and advancement of business objectives | Apr 28, 2025 |